In part 1 of this Exclusive Interview, Dr. Mark Molitch talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about teaching medical students about the specifics of nutrition as it relates to diabetes management.

In part 2 of this Exclusive Interview, Dr. Mark Molitch shares his thoughts about technology, the latest meds, and what's coming down the pike in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 3 of this Exclusive Interview, Dr. Mark Molitch talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about his ADA presentation on resulting diabetes diagnoses or hyperglycemia following islet pancreatic transplant surgery.

In part 4 of this Exclusive Interview, Dr. Mark Molitch shares his thoughts on the latest diabetes drug class, SGLT2, in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 5 of this Exclusive Interview, Dr. Mark Molitch explains the changes in diabetes care that have resulted in the dramatic decrease in renal failure in diabetes patients in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 6 of this Exclusive Interview, Dr. Mark Molitch explains the diabetes treatment objective in patients who have undergone a transplant in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 7, the conclusion of this Exclusive Interview, Dr. Mark Molitch talks with with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the importance of good blood glucose control and continued control in post-transplant patients as referenced in his ADA presentation.